Investment Summary |
|
---|---|
Date | 2021-03-22 |
Target | XyloCor Therapeutics |
Sector | Leisure |
Investor(s) | EQT Life Sciences |
Deal Type | Venture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1987 |
PE ASSETS | 2.0B USD |
Size | Large |
Type | Sector Focused |
DEAL STATS | # |
---|---|
Overall | 35 of 47 |
Sector (Leisure) | 1 of 1 |
Type (Venture) | 29 of 39 |
State (Pennsylvania) | 1 of 1 |
Country (United States) | 7 of 11 |
Year (2021) | 3 of 12 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-02-25 |
Simplify
Sunnyvale, California, United States Simplify is a medical device company focused on cervical spinal disc arthroplasty, using innovative, MRI-compatible materials designed to optimize diagnostic imaging and decrease the need for ionizing radiation. Simplify was founded in 2013 and is based in Sunnyvale, California. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-06-07 |
Innovative Molecules
Munich, Germany Innovative Molecules is a drug development company focused on developing next-generation treatments for Herpes simplex-induced diseases. Innovative Molecules is based in Munich, Germany. |
Buy | - |